POSTER: ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis
Department
Internal Medicine
Document Type
Poster
Publication Title
Clinical Lymphoma Myeloma and Leukemia
Conference Name
Society of Hematologic Oncology (SOHO) Annual Meeting
Conference Date
2026-09-09 - 2026-09-12
First Page
S309
DOI
10.1016/S2152-2650(26)01127-4
Volume
26
Issue
Supplement 1
Publication Date
8-1-2026
Recommended Citation
Raza, M. Z., Arshad, H. M., Maqsood, M., Maqsood, M., Babar, A., & Gill, O. A. (2026). POSTER: ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia, 26 (Supplement 1), S309. https://doi.org/10.1016/S2152-2650(26)01127-4
COinS